Pharmaceuticals Companies By Peg Ratio

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Price To Earnings To Growth
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Price To Earnings To GrowthEfficiencyMarket RiskExp Return
1RDY Dr Reddys Laboratories
4.51
(0.12)
 1.55 
(0.18)
2NVS Novartis AG ADR
3.34
 0.14 
 1.24 
 0.17 
3NKTR Nektar Therapeutics
3.22
(0.02)
 5.63 
(0.13)
4ZTS Zoetis Inc
3.0
(0.05)
 1.58 
(0.07)
5PBH Prestige Brand Holdings
2.79
 0.03 
 2.33 
 0.08 
6AMPH Amphastar P
2.77
(0.31)
 2.27 
(0.70)
7RPRX Royalty Pharma Plc
2.36
 0.23 
 1.94 
 0.45 
8TAK Takeda Pharmaceutical Co
1.71
 0.13 
 1.22 
 0.15 
9PAHC Phibro Animal Health
1.66
 0.02 
 3.19 
 0.06 
10SUPN Supernus Pharmaceuticals
1.47
(0.08)
 2.65 
(0.22)
11NVO Novo Nordisk AS
1.42
(0.09)
 3.43 
(0.32)
12BMY Bristol Myers Squibb
1.35
 0.03 
 1.54 
 0.05 
13LLY Eli Lilly and
1.34
 0.10 
 1.86 
 0.19 
14SNY Sanofi ADR
1.24
 0.21 
 1.64 
 0.35 
15PRGO Perrigo Company PLC
1.14
 0.03 
 3.03 
 0.08 
16JNJ Johnson Johnson
1.12
 0.17 
 1.18 
 0.20 
17ELAN Elanco Animal Health
1.1
(0.11)
 2.02 
(0.23)
18ANIP ANI Pharmaceuticals
1.06
 0.06 
 2.52 
 0.15 
19ASRT Assertio Therapeutics
0.96
(0.08)
 2.71 
(0.21)
20TEVA Teva Pharma Industries
0.96
(0.03)
 4.32 
(0.12)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth. Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY